0IL8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - FibroGen Inc

Watchlist Manager

Watchlist

Price: 7.24 USD -6.64% Market Closed

Market Cap: $29.3m

	FibroGen Inc LSE:0IL8	US
	Plug Power Inc NASDAQ:PLUG	US
	10X Genomics Inc NASDAQ:TXG	US
	Compagnie de Saint Gobain SA OTC:CODGF	FR
	CME Group Inc NASDAQ:CME	US
	EDP SA OTC:EDPFY	PT
M	Molson Coors Canada Inc F:65K	CA
	Sanrio Co Ltd OTC:SNROF	JP

Profitability Summary

FibroGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

86% > 6%

Negative Operating Margin

-1 088%

Negative 3Y Average Operating Margin

-480%

Declining Operating Margin

-248% > -1 088%

Exceptional Net Margin

3 968%

Strong 3Y Average Net Margin

861%

Net Margin is Increasing

-247% > 3 968%

Negative Free Cash Flow Margin

-824%

Negative 3Y Average Free Cash Flow Margin

-270%

Declining Free Cash Flow Margin

-245% > -824%

Negative ROE

-145%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-105%

ROIC is Increasing

-168% > -69%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.